Company intelligence / Profile preview

Oshen Holdings

Ownership: Private
Development stage: Other

Overview

Oshen Holdings is a European-based family office investing in innovative biotech and medtech life sciences focused on improving quality of life as we age ("Better Ageing"). It leads or participates in funding rounds for early-stage companies developing novel therapeutics and medical devices. Recent activities include co-development agreements with Topadur Pharma AG for a topical treatment for alopecia and leading the Series A round for 4D Medicine, which develops bioresorbable medical device materials.

Therapeutic areas: OtherDermatology
Modalities: Small moleculeBiomaterial/Device
Industry: Investors

Partnerships

Topadur Pharma AG – co-development/licensing agreement on TOP-M119 for Greater China region4D Medicine – lead investor role/funding partner on bioresorbable implant technology development

Beyond the preview

Go deeper on Oshen Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oshen Holdings.